Gabriella de Oliveira¹, Daniela Macedo Mello Ortiz², Matheus Lopes da Silva², Cibelle Correia Cavalcante Lacerda², Marcos Flaminio Carmos Junior², Felipe Andres Ortiz Poblete², Sergio Charifker Ribeiro Martins², Leandro Lécio de Lima Sousa²*, Roberto Puertas Garcia¹ and Thallita Pereira Queiroz¹

¹Department of Oral Implantology and Dental Prosthetics - ICS UniFunorte - Centro Universitário Faculdades Unidas Norte de Minas - Recife, PE, Brazil
²Universidade de Araraquara - UNIARA, Brazil

*Corresponding Author: Lécio de Lima Sousa, Universidade de Araraquara - UNIARA, Brazil.

Received: June 13, 2022; Published: July 05, 2022

Abstract

Platelet aggregates are solutions derived from autologous blood submitted to the centrifugation and utilized to aid the tissue regeneration. The protocols of obtaining such solutions depend on several factors such as the radius of the centrifuge's rotor, the strength and the time of rotation, and the tube's material that are utilized. Taking in account the variability of the factors that interfere in the distribution of the growth factors present, the platelet aggregates evolve in each new method created, also altering its properties and there for its clinical applications, being able to associate to bone grafts, injected, utilized in wound covering, and there for, capable to aid in the regeneration of varied tissues. This review proposes to reunite and describe details about the procedures that compose the different types of platelet concentrates and their respective utilities in the sub-areas of healthcare in general. For this reason, a bibliographical research was made in chronological order taking upon as its starting point the creation of the fibrin glue and following until the most recent studies of which describe modern alternatives for regenerative therapy and coagulation simulation, in addition to publication of structural texts for clarification of the homeostasis mechanism, platelet anatomy and function, growth factors, and laboratory good practices when the procedure of the blood gathering and processing and subsequent application of the platelet aggregate created. It is hoped that this work may clarify the main divergences among the platelet aggregates, focusing in growing technologies.

Keywords: Regenerative Therapy; L-PRF; C-PRF; Alb-PRF; Current Applications; Historical

References

1. AV Hoffbrand and PAH Moss. “Fundamentos em Hematologia, Porto Alegre: Artmed”. Capítulo 24: Plaquetas, coagulação do sangue e hemostasia (2013): 315-322.
2. Macfarlane RG. “An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier”. Nature 202 (1964): 498-499.
3. Davie EW and Ratnoff OD. “Waterfall sequence for intrinsic blood clotting”. Science 145 (1964): 1310-1312.
4. Dohan Ehrenfest DM., et al. “Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives”. Muscle, Ligaments and Tendons Journal 1 (2014): 3-9.
5. Prakash S and Thakur A. “Platelet Concentrates: Past, Present and Future”. Journal of Oral and Maxillofacial Surgery 1 (2011): 45-49.
6. Castro AB., et al. “Regenerative potential of leucocyte- and platelet-rich fibrin. Part A: intra-bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta-analysis”. Journal of Clinical Periodontology 1 (2017): 67-82.
7. Dohan DM., et al. “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution”. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 3 (2006): e37-44.
8. Miron RJ., et al. “Standardization of relative centrifugal forces in studies related to platelet-rich fibrin”. Journal of Periodontology8 (2019): 817-820.
9. Everts PAM., et al. “Platelet-rich plasma and platelet gel: a review”. Journal of Extracorporeal Technology, Bloomsburg2 (2006): 174-187.
10. Holinstat M. “Normal platelet function”. Cancer and Metastasis Reviews 2 (2017): 195-198.
11. Ramírez JUC. “Use of Autologous Platelet Concentrates for the Treatment of Musculoskeletal Injuries in the Horse”. Tese (Doutorado em Filosofia) - Universidade Autônoma de Barcelona, Bellaterra 91 (2006).
12. Costa PA and Santos P. “Plasma rico em plaquetas: uma revisão sobre seu uso terapêutico”. Revista Brasileira de Análises Clínicas (RBAC) 4 (2016): 311-319.
13. Felippe Junior J. “O Fator de Crescimento Semelhante a Insulina (IGF-I) aumenta a proliferação celular, diminui a apoptose das células malignas, promove a angiogênese tumoral e facilita o aparecimento e a manutenção de vários tipos de câncer”. Associação Brasileira de Medicina Biomolecular e Nutrigenômica (2011): 444.
14. A relação entre RPM e RCF ou Força G. “Laboratório Multiusuários de Estudos em Biologia “LAMEB” da Universidade Federal de Santa Catarina” (2012).
15. Leal VL., et al. “Protocolos e Técnicas Laboratoriais de Rotina: Aplicações em biologia molecular, microbiologia, cultivo celular e farmacognosia. 1a Ediçã São Paulo: Tiki Books; Santa Cruz do Sul: UNISC (2019).
16. Laboratório Cerba-LCA. “Manual de Coleta e Catálogo de Exames”. Versão 4 (2018):
17. Chou TM., et al. “Autologous platelet concentrates in maxillofacial regenerative therapy”. The Kaohsiung Journal of Medical Sciences 5 (2020): 305-310.
18. Mohan SP., et al. “Platelet-rich plasma and platelet-rich fibrin in periodontal regeneration: A review”. Journal of Pharmacy and Bioallied Sciences6 (2019): 126-130.
19. Simon BI., et al. “Clinical and Histological Comparison of Extraction Socket Healing Following the Use of Autologous Platelet-Rich Fibrin Matrix (PRFM) to Ridge Preservation Procedures Employing Demineralized Freeze-Dried Bone Allograft Material and Membrane”. The Open Dentistry Journal 3 (2009): 92-99.
20. Anitua E. “Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants”. The International Journal of Oral and Maxillofacial Implants 4 (1999): 529-535.
21. Masuki H., et al. “Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF)”. International Journal of Implant Dentistry 1 (2016): 19.
22. BERNARDI Sara., et al. “Histological Characterization of Sacco's Concentrated Growth Factors Membrane”. International Journal of Morphology 1 (2017): 114-119.
23. Agrawal AA. “Evolution, current status and advances in application of platelet concentrate in periodontics and implantology”. World Journal of Clinical Cases 5 (2017): 159-171.
24. Ghanaati S., et al. “Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells”. Journal of Oral Implantology 6 (2014): 679-689.
25. Castro AB., et al. “Effect of different platelet-rich fibrin matrices for ridge preservation in multiple tooth extractions: A split-mouth randomized controlled clinical trial”. Journal of Clinical Periodontology 487 (2021): 984-995.
26. Choukroun J and Ghanaati S. “Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept”. European Journal of Trauma and Emergency Surgery 1 (2018): 87-95.
27. Tunalı , et al. “In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate”. British Journal of Oral and Maxillofacial Surgery 51.5 (2013): 438-443.
28. Mourão CFAB., et al. “Obtenção da fibrina rica em plaquetas injetável (i-PRF) e sua polimerização com enxerto ósseo: nota técnica”. Revista do Colégio Brasileiro de Cirurgiões 6 (2015): 421-423.
29. Miron RJ., et al. “A novel method for harvesting concentrated platelet-rich fibrin (C-PRF) with a 10-fold increase in platelet and leukocyte yields”. Clinical Oral Investigations 8 (2020): 2819-2828.
30. Miron RJ., et al. “A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation”. Journal of Biomedical Materials Research Part A 10 (2019): 2257-2271.
31. Lourenço ES., et al. “The in vitro release of cytokines and growth factors from fibrin
    membranes produced through horizontal centrifugation”. Journal of Biomedical Materials Research Part A 5 (2018): 1373-1380.
32. Fujioka-Kobayashi M., et al. “Biological characterization of an injectable platelet-rich fibrin mixture consisting of autologous albumin gel and liquid platelet-rich fibrin (Alb-PRF)”. Platelets1 (2021): 74-81.
33. Csönge L., et al. “Regenerative medicine: characterization of human bone matrix gelatin (BMG) and folded platelet-rich fibrin (F-PRF) membranes alone and in combination (sticky bone)”. Cell Tissue Bank (2021).
34. Kawase T., et al. “The heat-compression technique for the conversion of platelet-rich fibrin preparation to a barrier membrane with a reduced rate of biodegradation”. Journal of Biomedical Materials Research Part B: Applied Biomaterials 4 (2015): 825-831.
35. Vendramin FS and Franco D e Franco TR. “Método de obtenção do gel de plasma rico em plaquetas autólogo”. Revista Brasileira de Cirurgia Plástica 2 (2009): 212-218.
36. Simonpieri A., et al. “Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery”. Current Pharmaceutical Biotechnology 7 (2012): 1207-1230.
37. Boyapati L and Wang HL. “The role of platelet-rich plasma in sinus augmentation: a critical review”. Implant Dentistry 2 (2006): 160-170.
38. Kawase T., et al. “The Platelet Concentrates Therapy: From the Biased Past to the Anticipated Future”. Bioengineering3 (2020): 82.
39. Dohan DM., et al. “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution”. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 3 (2006): e37-44.
40. Dohan DM., et al. “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features”. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology3 (2006): e45-50.
41. Dohan DM., et al. “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology3 (2006): e51-55.
42. Choukroun J., et al. “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing”. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 3 (2006): e56-60.
43. Choukroun J., et al. “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift”. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 3 (2006): 299-303.
44. Dohan Ehrenfest DM., et al. “In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures”. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 3 (2009): 341-352.
45. Del Fabbro M., et al. “Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature”. European Journal of Cancer 1 (2015): 62-74.
46. Fortunato L., et al. “Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review”. Journal of Cranio-Maxillofacial Surgery 3 (2020): 268-285.
47. Asaka T., et al. “Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study”. Clinical Oral Investigations 7 (2017): 2165-2172.
48. Şahin O., et al. “Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: An institution's experience”. Journal of Clinical and Experimental Dentistry 8 (2020): e771-e776.
49. Giudice A., et al. “Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report”. Indian Journal of Dental Research 5 (2020): 813-818.
50. Areewong K., et al. “Platelet-rich fibrin to preserve alveolar bone sockets following tooth extraction: A randomized controlled trial”. Clinical Implant Dentistry and Related Research 6 (2019): 1156-1163.
51. Canellas JVDS., et al. “Platelet-rich fibrin in oral surgical procedures: a systematic review and meta-analysis”. International Journal of Oral and Maxillofacial Surgery 3 (2019): 395-414.
52. Baslarli O., et al. “Evaluation of osteoblastic activity in extraction sockets treated with platelet-rich fibrin”. Medicina Oral, Patologia Oral y Cirugia Bucal 20 (1 (2015): e111-116.
53. Kotsakis GA., et al. “Extraction Socket Management Utilizing Platelet Rich Fibrin: A Proof-of-Principle Study of the "Accelerated-Early Implant Placement" Concept”. Journal of Oral Implantology 2 (2016): 164-168.
54. Costa NS., et al. “Fibrina Rica em Plaquetas e sua Utilização no Levantamento de seios maxilares”. Trabalho de Conclusão de Curso, apresentado para obtenção do grau de Cirurgião Dentista no curso de Odontologia da Universidade do Extremo Sul Catarinense-UNESC (2019).
55. Pucetti MG., et al. “Fibrina rica em plaquetas e sua utilização na cirurgia de levantamento de assoalho de seio maxilar”. Research, Society and Development7 (2021).
56. Marques AC and Karam FK. “Elevação do Soalho de Seio Maxilar com L-PRF: Relato de Caso Clínico”. Rio Verde (2019).
57. Malzoni CMA. “Utilização da fibrina rica em plaquetas e leucócitos (L-PRF) em procedimentos cirúrgicos de elevação do assoalho do seio maxilar. Dissertação apresentada à Universidade Estadual Paulista (Unesp), Faculdade de Odontologia, Araraquara para obtenção do título de Mestre em Odontologia, na área de Periodontia”. Araraquara (2020).
58. Moura LS., et al. “Utilização da Fibrina Rica em Plaquetas na Elevação Sinusal com Instalação Imediata de Implantes Dentários”. Revista Odontológica de Araçatuba1 (2020): 24-29.
59. Oliveira GR., et al. “O uso da fibrina rica em plaquetas e leucócitos (L-PRF) na cirurgia de levantamento de seio maxilar associada à biomaterial – relato de caso clínico”. Revista de Odontologia da UNESP 49 (2020):
60. Diana C., et al. “Does platelet-rich fibrin have a role in osseointegration of immediate implants? A randomized, single-blind, controlled clinical trial”. International Journal of Oral and Maxillofacial Surgery 9 (2018): 1178-1188.
61. Öncü E and Alaaddinoğlu EE. “The effect of platelet-rich fibrin on implant stability”. The International Journal of Oral and Maxillofacial Implants3 (2015): 578-582.
62. Öncü E., et al. “Positive effect of platelet rich fibrin on osseointegration”. Medicina Oral, Patologia Oral y Cirugia Bucal 5 (2016): e601-607.
63. E Öncü., et al. “A new strategy to enhance osseointegration in rabbit models: histomorphometric study”. International Journal of Oral and Maxillofacial Surgery10 (2013): 1266
64. El-Dessouky HF and Ibrahim SS. “Evaluation of implant osseointegration in experimentally induced osteoporosis using autologus platelet-rich fibrin (PRF): a comparative stury”.D.J 58.1 (2012).
65. Ravi S and Santhanakrishnan M. “Mechanical, chemical, structural analysis and comparative release of PDGF-AA from L-PRF, A-PRF and T-PRF - an in vitro study”. Biomaterials Research24 (2020): 16.
66.  

Citation

Citation: Leandro Lécio de Lima Sousa., et al. “Platelet Concentrates: A Literature Review Focusing on New Technologies". Acta Scientific Dental Sciences 6.8 (2022): 21-30.

Copyright

Copyright: © 2022 Leandro Lécio de Lima Sousa., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.